The global intellectual property landscape of induced pluripotent stem cell technologies.

Nat Biotechnol. 2014 Aug;32(8):742-8. doi: 10.1038/nbt.2975.

The global intellectual property landscape of induced pluripotent stem cell technologies.

Roberts M, Wall IB, Bingham I, Icely D, Reeve B, Bure K, French A, Brindley DA.

Abstract

Abstract:

Will freedom to research and innovate be restricted as the induced pluripotent stem cell field advances toward the clinic, or are concerns premature within a rapidly changing ecosystem?